432 related articles for article (PubMed ID: 18452780)
1. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
Gudmundsdóttir IJ; Lang NN; Boon NA; Ludlam CA; Webb DJ; Fox KA; Newby DE
J Am Coll Cardiol; 2008 May; 51(18):1749-56. PubMed ID: 18452780
[TBL] [Abstract][Full Text] [Related]
2. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
3. Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans.
Gudmundsdóttir IJ; Megson IL; Kell JS; Ludlam CA; Fox KA; Webb DJ; Newby DE
Circulation; 2006 Oct; 114(15):1625-32. PubMed ID: 17015787
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of the contrasting effects of in vivo thrombin receptor activation (protease-activated receptor type 1) on the human vasculature.
Cleator JH; Vaughan DE
J Am Coll Cardiol; 2008 May; 51(18):1757-9. PubMed ID: 18452781
[No Abstract] [Full Text] [Related]
5. Vascular effects of apelin in vivo in man.
Japp AG; Cruden NL; Amer DA; Li VK; Goudie EB; Johnston NR; Sharma S; Neilson I; Webb DJ; Megson IL; Flapan AD; Newby DE
J Am Coll Cardiol; 2008 Sep; 52(11):908-13. PubMed ID: 18772060
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans.
Schindler C; Dobrev D; Grossmann M; Francke K; Pittrow D; Kirch W
Clin Pharmacol Ther; 2004 Jan; 75(1):49-59. PubMed ID: 14749691
[TBL] [Abstract][Full Text] [Related]
7. Acute tissue-type plasminogen activator release in human microvascular endothelial cells: the roles of Galphaq, PLC-beta, IP3 and 5,6-epoxyeicosatrienoic acid.
Muldowney JA; Painter CA; Sanders-Bush E; Brown NJ; Vaughan DE
Thromb Haemost; 2007 Feb; 97(2):263-71. PubMed ID: 17264956
[TBL] [Abstract][Full Text] [Related]
8. Proteinase-activated receptor-1 (PAR-1) activation contracts the isolated human renal artery in vitro.
Tognetto M; D'Andrea MR; Trevisani M; Guerrini R; Salvadori S; Spisani L; Daniele C; Andrade-Gordon P; Geppetti P; Harrison S
Br J Pharmacol; 2003 May; 139(1):21-7. PubMed ID: 12746219
[TBL] [Abstract][Full Text] [Related]
9. Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2.
Peterson EA; Sutherland MR; Nesheim ME; Pryzdial EL
J Cell Sci; 2003 Jun; 116(Pt 12):2399-408. PubMed ID: 12724354
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells.
Pape R; Rauch BH; Rosenkranz AC; Kaber G; Schrör K
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):534-40. PubMed ID: 18162607
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas.
Jin E; Fujiwara M; Pan X; Ghazizadeh M; Arai S; Ohaki Y; Kajiwara K; Takemura T; Kawanami O
Cancer; 2003 Feb; 97(3):703-13. PubMed ID: 12548614
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptors in vascular biology.
Coughlin SR
Thromb Haemost; 2001 Jul; 86(1):298-307. PubMed ID: 11487018
[TBL] [Abstract][Full Text] [Related]
14. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P
Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular actions of thrombin receptor activation in vivo.
Damiano BP; Cheung WM; Mitchell JA; Falotico R
J Pharmacol Exp Ther; 1996 Dec; 279(3):1365-78. PubMed ID: 8968361
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial vasopressin in the human forearm: pharmacodynamics and the role of nitric oxide.
Affolter JT; McKee SP; Helmy A; Jones CR; Newby DE; Webb DJ
Clin Pharmacol Ther; 2003 Jul; 74(1):9-16. PubMed ID: 12844130
[TBL] [Abstract][Full Text] [Related]
17. Receptor-activating peptides for PAR-1 and PAR-2 relax rat gastric artery via multiple mechanisms.
Kawabata A; Nakaya Y; Ishiki T; Kubo S; Kuroda R; Sekiguchi F; Kawao N; Nishikawa H; Kawai K
Life Sci; 2004 Oct; 75(22):2689-702. PubMed ID: 15369704
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.
Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009
[TBL] [Abstract][Full Text] [Related]
19. Identification of thrombin receptors in rat brain capillary endothelial cells.
Bartha K; Dömötör E; Lanza F; Adam-Vizi V; Machovich R
J Cereb Blood Flow Metab; 2000 Jan; 20(1):175-82. PubMed ID: 10616806
[TBL] [Abstract][Full Text] [Related]
20. Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Giannarelli C; Virdis A; De Negri F; Magagna A; Duranti E; Salvetti A; Taddei S
Circulation; 2009 Mar; 119(12):1625-33. PubMed ID: 19289643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
